Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

  1. Cabrera-Serrano, Antonio José 78
  2. Sánchez-Maldonado, José Manuel 78
  3. ter Horst, Rob 16
  4. Macauda, Angelica 2
  5. García-Martín, Paloma 1
  6. Benavente, Yolanda 31718
  7. Landi, Stefano 9
  8. Clay-Gilmour, Alyssa 24
  9. Niazi, Yasmeen 2627
  10. Espinet, Blanca 56
  11. Rodríguez-Sevilla, Juan José 13
  12. Pérez, Eva María 1
  13. Maffei, Rossana 14
  14. Blanco, Gonzalo 56
  15. Giaccherini, Matteo 9
  16. Cerhan, James R. 15
  17. Marasca, Roberto 14
  18. López-Nevot, Miguel Ángel 12
  19. Chen-Liang, Tzu 25
  20. Thomsen, Hauke 33
  21. Gámez, Irene 25
  22. Campa, Daniele 9
  23. Moreno, Víctor 173132
  24. de Sanjosé, Silvia 317
  25. Marcos-Gragera, Rafael 3353637
  26. García-Álvarez, María 11
  27. Dierssen-Sotos, Trinidad 34
  28. Jerez, Andrés 10
  29. Butrym, Aleksandra 38
  30. Norman, Aaron D. 15
  31. Luppi, Mario 14
  32. Slager, Susan L. 2829
  33. Hemminki, Kari 1920
  34. Li, Yang 2223
  35. Berndt, Sonja I. 21
  36. Casabonne, Delphine 317
  37. Alcoceba, Miguel 11
  38. Puiggros, Anna 56
  39. Netea, Mihai G. 2234
  40. Försti, Asta 2627
  41. Canzian, Federico 2
  42. Sainz, Juan 37830
  43. Show all authors +
  1. 1 Hospital Campus de la Salud, PTS, 18016 Granada, Spain
  2. 2 Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
  3. 3 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain
  4. 4 Faculty of Medicine, University of Cantabria, 39011 Santander, Spain
  5. 5 Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain
  6. 6 Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain
  7. 7 Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain
  8. 8 Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain
  9. 9 Department of Biology, University of Pisa, 56126 Pisa, Italy
  10. 10 Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, 08035 Barcelona, Spain
  11. 11 Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain
  12. 12 Immunology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain
  13. 13 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  14. 14 Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy
  15. 15 Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
  16. 16 CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria
  17. 17 Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain
  18. 18 CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
  19. 19 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
  20. 20 Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic
  21. 21 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA
  22. 22 Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
  23. 23 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany
  24. 24 Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA
  25. 25 Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain
  26. 26 Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
  27. 27 Hopp Children’s Cancer Center (KiTZ), 69120 Heidelberg, Germany
  28. 28 Division of Computational Genomics, Mayo Clinic, Rochester, MN 85054, USA
  29. 29 Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
  30. 30 Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada (UGR), 18012 Granada, Spain
  31. 31 Cancer Prevention and Control Program, Unit of Biomarkers and Susceptibility, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, 08907 Barcelona, Spain
  32. 32 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain
  33. 33 MSB Medical School Berlin, D-14197 Berlin, Germany
  34. 34 Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany
  35. 35 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain
  36. 36 Department of Nursing, Universitat de Girona, 17007 Girona, Spain
  37. 37 Josep Carreras Leukemia Research Institute, 08916 Girona, Spain
  38. 38 Department of Cancer Prevention and Therapy, Medical University of Wrocław, 50-556 Wrocław, Poland
Show affiliations +
Journal:
International Journal of Molecular Sciences

ISSN: 1422-0067

Year of publication: 2023

Volume: 24

Issue: 9

Pages: 8005

Type: Article

DOI: 10.3390/IJMS24098005 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: International Journal of Molecular Sciences

Sustainable development goals

€ View funding

Funding information

Funders

  • European Union’s Horizon 2020 research and innovation program
    • 856620
  • Instituto de Salud Carlos III and FEDER
    • PI17/02256
    • PI20/01845
  • Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER
    • PY20/01282
  • US National Cancer Institute
    • P50 CA97274
    • R01 CA92153

Bibliographic References

  • Alaggio, (2022), Leukemia, 36, pp. 1720, 10.1038/s41375-022-01620-2
  • Yao, (2022), Biomed. Eng. Online, 21, pp. 4, 10.1186/s12938-021-00973-6
  • Parikh, (2014), Haematologica, 99, pp. 140, 10.3324/haematol.2013.086066
  • Alrawashdh, (2021), Ann. Hematol., 100, pp. 2501, 10.1007/s00277-021-04600-1
  • Hallek, (2021), Am. J. Hematol., 96, pp. 1679, 10.1002/ajh.26367
  • Rossi, (2013), Blood, 121, pp. 1403, 10.1182/blood-2012-09-458265
  • Berndt, (2016), Nat. Commun., 7, pp. 10933, 10.1038/ncomms10933
  • Law, (2017), Nat. Commun., 8, pp. 14175, 10.1038/ncomms14175
  • Slager, (2011), Blood, 117, pp. 1911, 10.1182/blood-2010-09-308205
  • Broderick, (2008), Nat. Genet., 40, pp. 1204, 10.1038/ng.219
  • Call, (1994), Mayo Clin. Proc., 69, pp. 323, 10.1016/S0025-6196(12)62215-0
  • Lin, (2021), Nat. Commun., 12, pp. 665, 10.1038/s41467-020-20822-9
  • Macauda, (2022), Cancer Epidemiol. Biomark. Prev., 31, pp. 1863, 10.1158/1055-9965.EPI-22-0043
  • Diez, (2022), Blood Cancer J., 12, pp. 79, 10.1038/s41408-022-00676-8
  • Wu, (2018), Biol. Res., 51, pp. 39, 10.1186/s40659-018-0189-0
  • Canzian, (2022), Eur. J. Hum. Genet., 30, pp. 474, 10.1038/s41431-021-00986-8
  • Li, (2016), Cell, 167, pp. 1099, 10.1016/j.cell.2016.10.017
  • Orru, (2013), Cell, 155, pp. 242, 10.1016/j.cell.2013.08.041